AZN vs JNJ
AstraZeneca PLC · Johnson & Johnson
Relative return (rebased to 100)
Key stats
| Metric | AZN | JNJ |
|---|---|---|
| Price | $186.76 | $280.78 |
| Market Cap | $289.48B | $675.92B |
| P/E | 28.31 | 25.22 |
| P/B | 5.95 | 8.29 |
| P/S | 4.93 | 7.18 |
| ROE | 21.0% | 32.9% |
| Net Margin | 17.4% | 28.5% |
| Gross Margin | 81.9% | 67.9% |
| Revenue Growth | 8.6% | 6.0% |
| Dividend Yield | 1.68% | 1.83% |
| EPS | $6.60 | $11.13 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.